Cargando…

Human melanoma immunotherapy using tumor antigen-specific T cells generated in humanized mice

A major factor hindering the exploration of adoptive immunotherapy in preclinical settings is the limited availability of tumor-reactive human T cells. Here we developed a humanized mouse model that permits large-scale production of human T cells expressing the engineered melanoma antigen MART-1-spe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Zheng, Xia, Jinxing, Fan, Wei, Wargo, Jennifer, Yang, Yong-Guang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper: Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872726/ https://www.ncbi.nlm.nih.gov/pubmed/26824989 http://dx.doi.org/10.18632/oncotarget.7044

Ejemplares similares

Human Immune System Mice With Autologous Tumor for Modeling Cancer Immunotherapies
por: Sun, Liguang, et al.
Publicado: (2020)

Generation of Pure Highly Functional Human Anti-Tumor Specific Cytotoxic T Lymphocytes With Stem Cell-Like Memory Features for Melanoma Immunotherapy
por: Hamieh, Mohamad, et al.
Publicado: (2021)

Modeling Human Leukemia Immunotherapy in Humanized Mice
por: Xia, Jinxing, et al.
Publicado: (2016)

Posttransplant Hemophagocytic Lymphohistiocytosis Driven by Myeloid Cytokines and Vicious Cycles of T-Cell and Macrophage Activation in Humanized Mice
por: Yoshihara, Satoshi, et al.
Publicado: (2019)

The role of lncRNAs in the tumor microenvironment and immunotherapy of melanoma
por: Zhou, Wencheng, et al.
Publicado: (2022)

Targeted Co-delivery of Tumor Antigen and α-Galactosylceramide to CD141(+) Dendritic Cells Induces a Potent Tumor Antigen-Specific Human CD8(+) T Cell Response in Human Immune System Mice
por: Huang, Jing, et al.
Publicado: (2020)

Antigen-Specific Immunotherapy for Treatment of Autoimmune Liver Diseases
por: Richardson, Naomi, et al.
Publicado: (2020)

Novel Tumor-Specific Antigens for Immunotherapy Identified From Multi-omics Profiling in Thymic Carcinomas
por: Fang, Wentao, et al.
Publicado: (2021)

Improving Antigenic Peptide Vaccines for Cancer Immunotherapy Using a Dominant Tumor-specific T Cell Receptor
por: Buhrman, Jonathan D., et al.
Publicado: (2013)

Potential for Antigen-Specific Tolerizing Immunotherapy in Systematic Lupus Erythematosus
por: Robinson, Sean, et al.
Publicado: (2021)

Human leukocyte antigen and tumor immunotherapy (Review)
por: Liu, Da-Hua, et al.
Publicado: (2023)

Perspectives on Chimeric Antigen Receptor T-Cell Immunotherapy for Solid Tumors
por: Kosti, Paris, et al.
Publicado: (2018)

T-Cell Immunotherapies Targeting Histocompatibility and Tumor Antigens in Hematological Malignancies
por: Janelle, Valérie, et al.
Publicado: (2020)

Overcoming Obstacles in the Development of Antigen-Specific Immunotherapies for Type 1 Diabetes
por: Thomas, Ranjeny, et al.
Publicado: (2021)

Comparison of Two Strategies to Generate Antigen-Specific Human Monoclonal Antibodies: Which Method to Choose for Which Purpose?
por: Ehlers, Anna M., et al.
Publicado: (2021)

Human Thymic Involution and Aging in Humanized Mice
por: Tong, Qing-Yue, et al.
Publicado: (2020)

Tumor-Derived Autophagosomes (DRibbles) Activate Human B Cells to Induce Efficient Antigen-Specific Human Memory T-Cell Responses
por: Ren, Hongyan, et al.
Publicado: (2021)

Immunotherapy for Prostate Cancer: Lessons from Responses to Tumor-Associated Antigens
por: Westdorp, Harm, et al.
Publicado: (2014)

Laboratory Mice – A Driving Force in Immunopathology and Immunotherapy Studies of Human Multiple Myeloma
por: Pisano, Michael, et al.
Publicado: (2021)

Human Tumor Antigens and Cancer Immunotherapy
por: Vigneron, Nathalie
Publicado: (2015)

Tolerogenic Immunotherapy: Targeting DC Surface Receptors to Induce Antigen-Specific Tolerance
por: Castenmiller, Charlotte, et al.
Publicado: (2021)

Alloantibody Generation and Effector Function Following Sensitization to Human Leukocyte Antigen
por: Hickey, Michelle J., et al.
Publicado: (2016)

Deciphering the potential roles of ferroptosis in regulating tumor immunity and tumor immunotherapy
por: Gu, Xu, et al.
Publicado: (2023)

Revolution of CAR Engineering For Next-Generation Immunotherapy In Solid Tumors
por: Yu, Tao, et al.
Publicado: (2022)

Editorial: Next generation γδ T cell-based tumor immunotherapy
por: Tan, Andy Hee-Meng, et al.
Publicado: (2022)

Allopurinol reduces antigen-specific and polyclonal activation of human T cells
por: Pérez-Mazliah, Damián, et al.
Publicado: (2012)

Identifying tumor antigens and immune subtypes of renal cell carcinoma for immunotherapy development
por: Chen, Xinglin, et al.
Publicado: (2022)

RAF Inhibitor Therapy Promotes Melanocytic Antigen Expression and Enhanced Anti-Tumor Immunity in Melanoma
por: Reuben, Alexandre, et al.
Publicado: (2014)

Tumor Immune Microenvironment Characterization Identifies Prognosis and Immunotherapy-Related Gene Signatures in Melanoma
por: Liu, Dan, et al.
Publicado: (2021)

TCR Analyses of Two Vast and Shared Melanoma Antigen-Specific T Cell Repertoires: Common and Specific Features
por: Simon, Sylvain, et al.
Publicado: (2018)

AIRE polymorphism, melanoma antigen-specific T cell immunity, and susceptibility to melanoma
por: Conteduca, Giuseppina, et al.
Publicado: (2016)

An estrogen response-related signature predicts response to immunotherapy in melanoma
por: Lin, Min, et al.
Publicado: (2023)

Unleashing Natural Killer Cells in the Tumor Microenvironment–The Next Generation of Immunotherapy?
por: Ben-Shmuel, Aviad, et al.
Publicado: (2020)

Modeling the Tumor Microenvironment and Cancer Immunotherapy in Next-Generation Humanized Mice
por: Chen, Anna, et al.
Publicado: (2023)

Large-Scale Generation of Human Allospecific Induced Tregs With Functional Stability for Use in Immunotherapy in Transplantation
por: Alvarez-Salazar, Evelyn Katy, et al.
Publicado: (2020)

Specific Protein Antigen Delivery to Human Langerhans Cells in Intact Skin
por: Rentzsch, Mareike, et al.
Publicado: (2021)

Sharpening the Edge for Precision Cancer Immunotherapy: Targeting Tumor Antigens through Oncolytic Vaccines
por: Holay, Namit, et al.
Publicado: (2017)

Quantitative spatial evaluation of tumor-immune interactions in the immunotherapy setting of metastatic melanoma lymph nodes
por: Maus, Rachel L. G., et al.
Publicado: (2022)

The effect of organ-specific tumor microenvironments on response patterns to immunotherapy
por: Conway, Jordan W., et al.
Publicado: (2022)

Single-Cell Transcriptomic Analysis Reveals a Tumor-Reactive T Cell Signature Associated With Clinical Outcome and Immunotherapy Response In Melanoma
por: Yan, Min, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_89ba6j0k5mtu4af7s33r15ttea